Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathias Loft

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Bioconjugate Chemistry|July 12, 2016
Preclinical Study on GRPR-Targeted (68)Ga-Probes for PET Imaging of Prostate CancerYao Sun, Xiaowei Ma, Zhe Zhang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 2020
<sup>64</sup>Cu-DOTATATE PET/CT and Prediction of Overall and Progression-Free Survival in Patients with Neuroendocrine NeoplasmsEsben Andreas Carlsen, Camilla Bardram Johnbeck, Tina Binderup, et al.
EJNMMI Research|May 28, 2022
A convolutional neural network for total tumor segmentation in [<sup>64</sup>Cu]Cu-DOTATATE PET/CT of patients with neuroendocrine neoplasmsEsben Andreas Carlsen, Kristian Lindholm, Amalie Hindsholm, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 3, 2021
A Randomized, Factorial Phase II Study to Determine the Optimal Dosing Regimen for <sup>68</sup>Ga-Satoreotide Trizoxetan as an Imaging Agent in Patients with Gastroenteropancreatic Neuroendocrine TumorsIrene Virgolini, Shadfar Bahri, Andreas Kjaer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 24, 2020
<sup>64</sup>Cu-DOTATATE PET in Patients with Neuroendocrine Neoplasms: Prospective, Head-to-Head Comparison of Imaging at 1 Hour and 3 Hours After InjectionMathias Loft, Esben A Carlsen, Camilla B Johnbeck, et al.
Clinical Nuclear Medicine|November 12, 2024
First-in-Human: Simultaneous Hyperpolarized 1- 13 C-Pyruvate Magnetic Resonance Spectroscopy and 18 F-FDG PET (hyperPET) Imaging of a Patient With LymphomaMathias Loft, Andreas Clemmensen, Emil Nørgaard Christensen, et al.
Diagnostics (Basel, Switzerland)|October 23, 2021
[<sup>68</sup>Ga]Ga-NODAGA-E[(cRGDyK)]<sub>2</sub> Angiogenesis PET/MR in a Porcine Model of Chronic Myocardial InfarctionSimon Bentsen, Andreas Clemmensen, Mathias Loft, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 19, 2022
First-in-Humans PET Imaging of Tissue Factor in Patients with Primary and Metastatic Cancers Using <sup>18</sup>F-labeled Active-Site Inhibited Factor VII (<sup>18</sup>F-ASIS): Potential as Companion DiagnosticMathias Loft, Camilla Christensen, Malene M Clausen, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Bioconjugate Chemistry|July 12, 2016
Preclinical Study on GRPR-Targeted (68)Ga-Probes for PET Imaging of Prostate CancerYao Sun, Xiaowei Ma, Zhe Zhang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 2020
<sup>64</sup>Cu-DOTATATE PET/CT and Prediction of Overall and Progression-Free Survival in Patients with Neuroendocrine NeoplasmsEsben Andreas Carlsen, Camilla Bardram Johnbeck, Tina Binderup, et al.
EJNMMI Research|May 28, 2022
A convolutional neural network for total tumor segmentation in [<sup>64</sup>Cu]Cu-DOTATATE PET/CT of patients with neuroendocrine neoplasmsEsben Andreas Carlsen, Kristian Lindholm, Amalie Hindsholm, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 3, 2021
A Randomized, Factorial Phase II Study to Determine the Optimal Dosing Regimen for <sup>68</sup>Ga-Satoreotide Trizoxetan as an Imaging Agent in Patients with Gastroenteropancreatic Neuroendocrine TumorsIrene Virgolini, Shadfar Bahri, Andreas Kjaer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 24, 2020
<sup>64</sup>Cu-DOTATATE PET in Patients with Neuroendocrine Neoplasms: Prospective, Head-to-Head Comparison of Imaging at 1 Hour and 3 Hours After InjectionMathias Loft, Esben A Carlsen, Camilla B Johnbeck, et al.
Clinical Nuclear Medicine|November 12, 2024
First-in-Human: Simultaneous Hyperpolarized 1- 13 C-Pyruvate Magnetic Resonance Spectroscopy and 18 F-FDG PET (hyperPET) Imaging of a Patient With LymphomaMathias Loft, Andreas Clemmensen, Emil Nørgaard Christensen, et al.
Diagnostics (Basel, Switzerland)|October 23, 2021
[<sup>68</sup>Ga]Ga-NODAGA-E[(cRGDyK)]<sub>2</sub> Angiogenesis PET/MR in a Porcine Model of Chronic Myocardial InfarctionSimon Bentsen, Andreas Clemmensen, Mathias Loft, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 19, 2022
First-in-Humans PET Imaging of Tissue Factor in Patients with Primary and Metastatic Cancers Using <sup>18</sup>F-labeled Active-Site Inhibited Factor VII (<sup>18</sup>F-ASIS): Potential as Companion DiagnosticMathias Loft, Camilla Christensen, Malene M Clausen, et al.
Pageof 2